Dilution of equity value resulting from the exercise of stock acquisition rights
First written in FY2021. 12 of 17 entries say "Materialised", first in FY2022-Q2. Latest entry: FY2026.
Landnet moved to the "Worse" side of this theme in 2021, 1 year after the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
32 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「The Company's total number of issued shares was 23,972,000 as of the end of the consolidated fiscal year. If all of these stock acquisition rights were exercised, 388,800 new shares would be issued, potentially diluting the value per share.」
The number of shares that could be newly issued if all stock acquisition rights were exercised increased from 212,000 in the previous fiscal year to 388,800. - 2026-09-11MaterialisedRevision of earnings forecasts
「Proceeds from the issuance of shares through the exercise of stock acquisition rights」
Shares were issued during the current fiscal year through the exercise of stock acquisition rights. - FY2026-H1MaterialisedAnnual report
「1 August 2025–31 October 2025 (Note) 1 5,600 11,974,000」
5,600 shares were issued through exercise of stock acquisition rights during the current interim period, and 7,200 shares were issued between 2 November 2025 and 31 January 2026. Part of the potential dilution has materialized as actual share issuance. - FY2025WorsenedAnnual report
「The total number of issued shares at the end of the current consolidated fiscal year was 11,968,400. If all of these stock acquisition rights are exercised, 212,000 new shares would be issued and the value per share could be diluted.」
Potential shares issuable upon full exercise of all stock acquisition rights increased from 122,800 in the previous fiscal year to 212,000. - FY2025-H1MaterialisedAnnual report
「2 November 2024–31 January 2025 (Note) 2 8,800 11,960,000 1,441 707,580 1,441 607,580 (Note) 2 Increase due to exercise of stock acquisition rights.」
8,800 shares were issued through exercise of stock acquisition rights during the current interim consolidated accounting period, increasing total issued shares to 11,960,000. Part of the potential dilution has materialized as actual share issuance. - FY2024MaterialisedAnnual report
「The total number of issued shares at the end of the current consolidated fiscal year was 5,975,600. If all of these stock acquisition rights are exercised, 122,800 new shares would be issued and the value per share could be diluted.」
23,800 shares were issued through exercise of stock acquisition rights during the year, increasing total issued shares to 5,975,600. Potential shares issuable upon full exercise totaled 122,800. - FY2024-Q3MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
11,600 shares were issued through exercise of stock acquisition rights between 1 February and 30 April 2024, increasing total issued shares to 5,965,400. Part of the potential dilution has continued to materialize as actual share issuance. - FY2024-Q2MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
2,000 shares were issued through exercise of stock acquisition rights between 1 November 2023 and 31 January 2024, increasing total issued shares to 5,953,800. Part of the potential dilution has materialized as actual share issuance. - FY2023WorsenedAnnual report
「The total number of issued shares at the end of the current consolidated fiscal year was 5,951,800. If all of these stock acquisition rights are exercised, 155,600 new shares would be issued and the value per share could be diluted.」
Exercise of stock acquisition rights resulted in the issuance of 8,800 shares during the year, increasing total issued shares to 5,951,800. The number of shares potentially issuable upon full exercise also increased to 155,600. - FY2023-Q3MaterialisedAnnual report
「1 February 2023–30 April 2023 (Note) 1,600 5,951,800」
1,600 shares were issued through exercise of stock acquisition rights during the third quarter, increasing total issued shares to 5,951,800. Part of the potential dilution has materialized as actual share issuance. - FY2023-Q2MaterialisedAnnual report
「1 November 2022–31 January 2023 (Note) 1 1,200 2,975,100 558 700,234 558 600,234」
1,200 shares were issued through exercise of stock acquisition rights during the second quarter. After the share split, total issued shares were 5,950,200, and part of the potential dilution has materialized as actual share issuance. - FY2023-Q1MaterialisedAnnual report
「1 August 2022–31 October 2022 6,000 2,973,900 (Note) 1 Increase due to exercise of stock acquisition rights.」
6,000 shares were issued through exercise of stock acquisition rights during the first quarter, increasing total issued shares to 2,973,900. Part of the potential dilution has materialized as actual share issuance. - FY2022MaterialisedAnnual report
「The total number of issued shares at the end of the current consolidated fiscal year was 2,967,900. If all of these stock acquisition rights are exercised, 90,800 new shares would be issued and the value per share could be diluted.」
Exercise of stock acquisition rights resulted in the issuance of 2,850 shares during the year, increasing total issued shares to 2,967,900. Part of the potential dilution has materialized as actual share issuance. - FY2022-Q3MaterialisedAnnual report
「1 February 2022–30 April 2022 (Note) 1 600 1,483,550 558 696,514 558 596,514」
600 shares were issued through exercise of stock acquisition rights during the third quarter, increasing total issued shares to 1,483,550. Part of the potential dilution has materialized as actual share issuance. - FY2022-Q2MaterialisedAnnual report
「Proceeds from issuance of shares through exercise of stock acquisition rights 2,697」
Proceeds from share issuance through exercise of stock acquisition rights were recorded, and total issued shares increased to 1,482,950. Part of the potential dilution has materialized as actual share issuance. - FY2022-Q1WorsenedAnnual report
「Fifth Series of Stock Acquisition Rights: 10,250 common shares of the company Sixth Series of Stock Acquisition Rights: 1,300 common shares of the company」
In addition to third-party allotment stock acquisition rights, rights were issued to employees, directors and audit and supervisory committee members, increasing the potential share count and the scope of dilution exposure. - FY2021First statedAnnual report
「The total number of issued shares at the end of the current consolidated fiscal year was 1,481,500. If all of these stock acquisition rights are exercised, 35,200 new shares would be issued and the value per share could be diluted.」
The potential issuance of 35,200 shares upon full exercise of stock acquisition rights granted to officers and employees is disclosed.